Commentary
Video
Author(s):
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on tissue and liquid biopsies for biomarker testing in NSCLC.
Perioperative Vorasidenib and Ivosidenib Remain Effective, Safe in IDH1+ Diffuse Glioma
Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD
Adding an HPK1 Inhibitor to Immune Checkpoint Inhibition May Be Effective in Solid Tumors
How to Apply Research Developments in ALK-Positive NSCLC: With Chandler Park, MD, and Tejas Patil, MD
Zorifertinib Receives NMPA Approval for EGFR+ NSCLC With CNS Metastases
Subcutaneous Pembrolizumab Plus Chemo Meets Pharmacokinetic End Points in NSCLC
Mirdametinib Improves HRQOL in Adult and Pediatric Patients With NF1-PN
Dr Schiff on PFS and OS Data With Temozolomide Plus Radiation in Grade II Glioma
Larotrectinib Induces Rapid, Durable Responses in Pediatric Patients With TRK Fusion+ CNS Tumors